Top Abstract Purchase Related
Home
>
Node
>
Subnode

Morphological and functional condition of the stomach in multiple sclerosis patients treated with prednisone

Chmielewski, H.; Chojnacki, J.; Klupińska, G.

Wiadomosci Lekarskie 42(5): 314-317

1989

ISSN/ISBN: 0043-5147
PMID: 2815751
Document Number: 332929
In 30 patients with multiple sclerosis treated with prednisone the morphological status of the gastric mucosa was assessed endoscopically and mikroscopically, and the secretory function of the stomach was studied determining hydrochloric acid, sialic acid and total glycoproteins in gastric juice before and after 6 weeks of prednisone treatment. After the treatment in 9 cases the symptoms and signs of gastritis were exacerbated, in 7 cases they were alleviated, and in gastric juice secretion of sialic acid was reduced in most cases.

Document emailed within 1 workday
Secure & encrypted payments

Lhermitte, F.; Marteau, R.; de Saxcé, H. 1987: Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up Revue Neurologique (Paris) 143(2): 98-107
Gusev, E.I.; Demina, T.L.; Boĭko, A.N.; Tatarinova, M.I. 1992: Clinico-immunological monitoring of the condition of patients with multiple sclerosis Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(2): 14-18
Tuszewski, M. 1977: Assessment of the functional and morphological condition of the liver in patients being prepared for surgical treatment of obesity Polski Tygodnik Lekarski 32(36): 1393-1395
Akhmedov, K.R.; Suleĭmanov, K.S.; Bakhadyrov, K.B.; Abidov, M.M. 1985: Functional and morphological status of the stomach and its correction in patients with allergic dermatoses Klinicheskaia Meditsina 63(7): 106-109
Zufarov, K.A.; Iuldashev, U.I.; Cherenok, Z.F. 1972: Functional and morphological condition of the mucosa of the small intestine in patients with chronic gastritis. (Data of aspiration enterobiopsy and radioisotope indications) Terapevticheskii Arkhiv 44(11): 77-81
Fedishin, P.S.; Biletskiĭ, V.I.; Shalimov, S.A.; Buryĭ, A.N.; Terzova, T.B. 1984: Clinico-functional and morphological characteristics of the stomach and duodenum of patients after pancreatic resection Vrachebnoe Delo 1984(7): 7-10
Buianov, V.M.; Balalykin, A.S.; Filimonov, M.I.; Kravchenko, N.I. 1974: Functional and morphological changes in the stomach, duodenum and extrahepatic bile ducts in patients with supraduodenal choledochoduodenoanastomoses Vestnik Khirurgii Imeni I. I. Grekova 112(4): 20-25
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Pokryszko-Dragan, A.; Bilińska, M.łg.; Gruszka, E.; Dubik-Jezierzańska, M. 2005: Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(113): 654-658
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Gubergrits, A.I. 1977: Functional condition of the stomach in the most important internal diseases Klinicheskaia Meditsina 55(2): 30-35
Wender, M.; Michałowska, G. 1986: IgG synthesis in the cerebrospinal fluid in patients with the chronic progressive phase of multiple sclerosis treated with cyclophosphamide and ACTH Neurologia i Neurochirurgia Polska 20(6): 536-541
Losy, J.; Michałowska-Wender, G.; Kurdyńska, A.; Wender, M.ła. 2005: CCL2 (MCP-1) and CCL5 (RANTES) levels in the peripheral blood of multiple sclerosis patients treated with Glatiramer Acetate (Copaxone) Folia Neuropathologica 43(3): 153-155
Gaĭkova, O.N.; Bisaga, G.N.; Onishchenko, L.S.; Chikurov, A.A.; Pakhomov, I.M.; Pozdniakov, A.V.; Odinak, M.M. 2006: New morphological data on multiple sclerosis Arkhiv Patologii 68(2): 28-34
Broom, N.D.; Poole, C.A. 1982: A functional-morphological study of the tidemark region of articular cartilage maintained in a non-viable physiological condition Journal of Anatomy 135(Part 1): 65-82
Macheret, E.L.; Iarosh, A.A.; Korchemnyĭ, V.A.; Panchenko, L.P. 1987: Morphological comparisons of disorders in multiple sclerosis and experimental allergic encephalomyelitis Vrachebnoe Delo 12: 64-68
Danilova, L.V.; Popova, E.V.; Kulakova, O.G.; Tsareva, E.I.; Favorov, A.V.; Favorova, O.O.; Boĭko, A.N. 2014: The activation of the type i interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(2 Part 2): 72-77
Silver, R.M.; Warrick, J.H.; Kinsella, M.B.; Staudt, L.S.; Baumann, M.H.; Strange, C. 1993: Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease Journal of Rheumatology 20(5): 838-844
Mezei, Z.; Bereczki, D.án.; Csiba, L.ás.ó; Csépány, T.ün. 2005: Application of the Multiple Sclerosis Functional Composite in Debrecen Ideggyogyaszati Szemle 58(3-4): 113-118